PD-1 Inhibitor Combined with Radiotherapy and GM-CSF with or not IL-2 (PRaG regimen) in Patients with Microsatellite Stable Metastatic Colorectal Cancer

被引：0
|
作者：
Yang, J. [1 ]
Xing, P. [1 ]
Kong, Y. [1 ]
Xu, M. [1 ]
Zhang, L. [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2341
引用
收藏
页码：E154 / E154
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Fruquintinib Plus PD-1 Inhibitors Versus Regorafenib Plus PD-1 Inhibitors in Refractory Microsatellite Stable Metastatic Colorectal Cancer
    Sun, Liying
    Huang, Shenglan
    Li, Dan
    Mao, Ye
    Wang, Yurou
    Wu, Jianbing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Treatment with GM-CSF and IL-2 in patients with metastatic colorectal carcinoma induced high serum levels of neopterin and sIL-2R, an indicator of immune suppression
    Skog, ALH
    Wersäll, P
    Ragnhammar, P
    Frödin, JE
    Mellstedt, H
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (05) : 255 - 262
  • [23] Treatment with GM-CSF and IL-2 in patients with metastatic colorectal carcinoma induced high serum levels of neopterin and sIL-2R, an indicator of immune suppression
    Hjelm A.-L. Skog
    P. Wersäll
    P. Ragnhammar
    J.-E. Frödin
    Håkan Mellstedt
    Cancer Immunology, Immunotherapy, 2002, 51 : 255 - 262
  • [24] Efficacy analysis of regorafenib combined with PD-1 inhibitors in elderly patients with metastatic colorectal cancer
    Chen, Beibei
    Zhao, Huichen
    Huang, Jinxi
    Lv, Huifang
    Xu, Weifeng
    Nie, Caiyun
    Wang, Jianzheng
    Zhao, Jing
    He, Yunduan
    Wang, Saiqi
    Chen, Xiaobing
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [25] Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer
    Chen, Beibei
    Zhao, Huichen
    Huang, Jinxi
    Lv, Huifang
    Xu, Weifeng
    Nie, Caiyun
    Wang, Jianzheng
    Zhao, Jing
    He, Yunduan
    Wang, Saiqi
    Chen, Xiaobing
    BMC GERIATRICS, 2022, 22 (01)
  • [26] Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer
    Beibei Chen
    Huichen Zhao
    Jinxi Huang
    Huifang Lv
    Weifeng Xu
    Caiyun Nie
    Jianzheng Wang
    Jing Zhao
    Yunduan He
    Saiqi Wang
    Xiaobing Chen
    BMC Geriatrics, 22
  • [27] Synergistic effect of a GM-CSF transduced tumor cell vaccine and systemic IL-2 in the treatment of murine colorectal cancer hepatic metastases
    Jain, A
    Slansky, JE
    Matey, LC
    Allen, HE
    Pardoll, DM
    Schulick, RD
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S28 - S29
  • [28] Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNα in patients with metastatic melanoma
    G C de Gast
    D Batchelor
    M J Kersten
    F A Vyth-Dreese
    J Sein
    W F van de Kasteele
    W J Nooijen
    O E Nieweg
    M A de Waal
    W Boogerd
    British Journal of Cancer, 2003, 88 : 175 - 180
  • [29] Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNα in patients with metastatic melanoma
    de Gast, GC
    Batchelor, D
    Kersten, MJ
    Vyth-Dreese, FA
    Sein, J
    van de Kasteele, WF
    Nooijen, WJ
    Nieweg, OE
    de Waal, MA
    Boogerd, W
    BRITISH JOURNAL OF CANCER, 2003, 88 (02) : 175 - 180
  • [30] Phase II clinical trial of mutant Ras peptide vaccine in combination with GM-CSF and IL-2 in advanced cancer patients
    Achtar, M. S.
    Toubaji, A.
    Herrin, V.
    Gause, B.
    Hamilton, M.
    Berhens, R.
    Grollman, F.
    Bernstein, S.
    Khleif, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345